Increased expression of epithelial cell adhesion molecule (EPCAM) in rat hepatic tumors induced by diethylnitrosamine

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 8, 2012, Pages 3627-3630

  Kang, Jin Seok ^a  

^a Namseoul University   (South Korea)

Author keywords

Den; Epcam; Hepatocarcinogenesis; Pcna; Rat

Indexed keywords

ALKYLATING AGENT; CELL ADHESION MOLECULE; CYCLINE; DIETHYLNITROSAMINE; TUMOR ANTIGEN; TUMOR ASSOCIATED ANTIGEN GA733; TUMOR-ASSOCIATED ANTIGEN GA733;

ANIMAL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DRUG EFFECT; ENZYME IMMUNOASSAY; FISCHER 344 RAT; LIVER; LIVER TUMOR; MALE; METABOLISM; PATHOLOGY; RAT;

ALKYLATING AGENTS; ANIMALS; ANTIGENS, NEOPLASM; APOPTOSIS; CELL ADHESION MOLECULES; CELL PROLIFERATION; DIETHYLNITROSAMINE; IMMUNOENZYME TECHNIQUES; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, INBRED F344;

EID: 84873668748     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.8.3627     Document Type: Article

References (17)

1. Al-Hajj M, Clarke MF (2004). Self-renewal and solid tumor stem cells. Oncogene, 23, 7274-82.
2. Arsura M and Cavin LG (2005). Nuclear factor-kappaB and liver carcinogenesis. Cancer Lett, 229, 157-69.
3. Kang JS, Wanibuchi H, Morimura K, et al. (2007). Role of CYP2E1 in diethylnitrosamine-induced hepatocarcinogenesis in vivo. Cancer Res, 67, 11141-6.
4. Kenyon J, Gerson SL (2007). The role of DNA damage repair in aging of adult stem cells. Nucleic Acids Res, 35, 7557-65.
5. Litvinov SV, Velders MP, Bakker HA, et al. (1994). Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule. J Cell Biol, 125, 437-46.
6. Maetzel D, Denzel S, Mack B, et al. (2009). Nuclear signalling by tumour-associated antigen EpCAM. Nat Cell Biol, 11, 162-71.
7. Peto R, Gray R, Brantom P, et al. (1991). Effects on 4080 rats of chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine: a detailed dose-response study. Cancer Res, 51, 6415-51.
8. Pitot HC, Dragan YP, Teeguarden J, et al. (1996). Quantitation of multistage carcinogenesis in rat liver. Toxicol Pathol, 24, 119-128.
9. Sell S and Dunsford HA (1989). Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. Am J Pathol, 134, 1347-63.
10. Turner R, Lozoya O, Wang Y, et al. (2011). Human hepatic stemcell and maturational liver lineage biology. Hepatology, 53, 1035-45.
11. van der Gun BT, Melchers LJ, Ruiters MH, et al. (2010). EpCAM in carcinogenesis: the good, the bad or the ugly. Carcinogenesis, 31, 1913-21.
12. Verna L, Whysner J, Williams GM (1996). N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation. Pharmacol Ther, 71, 57-81.
13. Visvader JE, Lindeman GJ (2008). Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer, 8, 755-68.
14. Wicha MS, Liu S, Dontu G (2006). Cancer stem cells: an old idea-a paradigm shift. Cancer Res, 66, 1883-1890; discussion 1895-86.
15. Yamashita T, Forgues M, Wang W, et al. (2008). EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Res, 68, 1451-61.
16. Yamashita T, Ji J, Budhu A, et al. (2009). EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology, 136, 1012-24.
17. Yoon SM, Gerasimidou D, Kuwahara R, et al. (2011). Epithelial cell adhesion molecule (EpCAM) marks hepatocytes newly derived from stem/progenitor cells in humans. Hepatology, 53, 964-73.